Periprosthetic osteolysis: Genetics, mechanisms and potential therapeutic interventions

Canadian Journal of Surgery

Volumn 55, Issue 6, 2012, Pages 408-417

  Noordin, Shahryar ^a   Masri, Bassam ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLY(METHYL METHACRYLATE); TITANIUM;

ADAPTIVE IMMUNITY; ANIMAL; ARTHROPLASTY; BONE DEVELOPMENT; GENETICS; HUMAN; JOINT PROSTHESIS; METABOLISM; OSTEOLYSIS; PROSTHESIS FAILURE; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; ARTHROPLASTY, REPLACEMENT; BONE RESORPTION; HUMANS; JOINT PROSTHESIS; OSTEOGENESIS; OSTEOLYSIS; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; TITANIUM;

EID: 84872839731     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: 10.1503/cjs.003711     Document Type: Review

References (49)

1. Archibeck MJ, Jacobs JJ, Roebuck KA, et al. The basic science of periprosthetic osteolysis [review]. Instr Course Lect. 2001;50:185-95.
2. Pearle AD, Crow MK, Rakshit DS, et al. Distinct inflammatory gene pathways induced by particles. Clin Orthop Relat Res 2007;458:194.
3. Fritz EA, Glant TT, Vermes C, et al. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res A 2006;77:192.
4. Davies AP, Willert HG, Campbell PA, et al. An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-onmetal joint replacements. J Bone Joint Surg Am 2005;87:18.
5. Willert HG, Buchhorn GH, Fayyazi A, et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. J Bone Joint Surg Am 2005;87:28.
6. Hallab N, Merritt K, Jacobs JJ. Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 2001;83:428.
7. Gordon A, Kiss-Toth E, Stockley I, et al. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 2008;58:3157.
8. Malik MH, Jury F, Bayat A, et al. Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis 2007;66:1116.
9. Wilkinson JM, Wilson AG, Stockley I, et al. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res 2003;18:1995.
10. Ren W, Wu B, Peng X, et al. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(-/-) mice. J Orthop Res 2006; 24:1575.
11. Clohisy JC, Teitelbaum S, Chen S, et al. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J Orthop Res 2002;20:174.
12. Schwarz EM, Lu AP, Goater JJ, et al. Tumor necrosis factor-alpha /nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472.
13. Atkins GJ, Welldon KJ, Holding CA, et al. The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials 2009;30:3672.
14. Bylski D, Wedemeyer C, Xu J, et al. Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line. J Biomed Mater Res A 2009;89:707.
15. Baumann B, Seufert J, Jakob F, et al. Activation of NF-kappaB signalling and TNFalpha-expression in THP-1 macrophages by TiAlVand polyethylene-wear particles. J Orthop Res 2005;23:1241.
16. Granchi D, Cenni E, Savarino L, et al. Bone cement extracts modulate the osteoprotegerin/osteoprotegerin-ligand expression in MG63 osteoblast-like cells. Biomaterials 2002;23:2359.
17. Takatsuna H, Asagiri M, Kubota T, et al. Inhibition of RANKLinduced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1. J Bone Miner Res 2005;20:653.
18. Liu F, Zhu Z, Mao Y, et al. Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials 2009;30:1756.
19. Ren WP, Markel DC, Zhang R, et al. Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo. Biomaterials 2006;27:5161.
20. Yamanaka Y, Abu-Am Y, Faccio R, et al. Map kinase c-JUN N-terminal kinase mediates PMMA induction of osteoclasts. J Orthop Res 2006;24:1349.
21. Takei I, Takagi M, Santavirta S, et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J Biomed Mater Res 2000;52:613.
22. Sasaki K, Takagi M, Mandelin J, et al. Quantitative analysis of mRNA expression of TIMPs in the periprosthetic interface tissue of loose hips by real-time PCR system. J Biomed Mater Res 2001;58:605.
23. Nawrocki B, Polette M, Burlet H, et al. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene. J Bone Miner Res 1999;14:288.
24. Ahmed M, Bergström J, Lundblad H, et al. Sensory nerves in the interface membrane of aseptic loose hip prostheses. J Bone Joint Surg Br 1998;80:151.
25. Wedemeyer C, Neuerburg C, Pfeiffer A, et al. Polyethylene particleinduced bone resorption in substance P-deficient mice. Calcif Tissue Int 2007;80:268.
26. Qiu J, Beckman MJ, Qian J, et al. Simultaneous labeling of mast cell proteases and protease mRNAs at the bone-implant interface of aseptically loosened hip implants. J Orthop Res 2005;23:942.
27. Shen Z, Crotti TN, McHugh KP, et al. The role played by cell-substrate interactions in the pathogenesis of osteoclast-mediated peri-implant osteolysis. Arthritis Res Ther 2006;8:R70.
28. Nakashima Y, Sun DH, Trindade MC, et al. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am 1999;81:603.
29. Rakshit DS, Ly K, Sengupta TK, et al. Wear debris inhibition of antiosteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. J Bone Joint Surg Am 2006;88:788.
30. Schwarz EM, Benz EB, Lu AP, et al. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. J Orthop Res 2000;18:849.
31. Merkel KD, Erdmann JM, McHugh KP, et al. Tumor necrosis factoralpha mediates orthopedic implant osteolysis. Am J Pathol 1999;154:203.
32. Schwarz EM, Lu AP, Goater JJ, et al. Tumor necrosis factor-alpha /nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 2000;18:472.
33. Childs LM, Goater JJ, O'Keefe RJ, et al. Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 2001;16:338.
34. Koulouvaris P, Ly K, Ivashkiv LB, et al. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. J Orthop Res 2008;26:106.
35. Kwon SY, Lin T, Takei H, et al. Alterations in the adhesion behavior of osteoblasts by titanium particle loading: inhibition of cell function and gene expression. Biorheology 2001;38:161.
36. Rakshit DS, Lim JT, Ly K, et al. Involvement of complement receptor 3 (CR3) and scavenger receptor in macrophage responses to wear debris. J Orthop Res 2006;24:2036.
37. Vermes C, Roebuck KA, Chandrasekaran R, et al. Particulate wear debris activates protein tyrosine kinases and nuclear factor kappaB, which down-regulates type I collagen synthesis in human osteoblasts. J Bone Miner Res 2000;15:1756.
38. von Knoch M, Jewison DE, Sibonga JD, et al. Decrease in particleinduced osteolysis in obese (ob/ob) mice. Biomaterials 2004;25:4675.
39. Zhang X, Morham SG, Langenbach R, et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res 2001;16:660.
40. Childs LM, Goater JJ, O'Keefe RJ, et al. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg Am 2001;83:1789.
41. Childs LM, Paschalis EP, Xing L, et al. In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res 2002;17:192.
42. Goater JJ, O'Keefe RJ, Rosier RN, et al. Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 2002;20:169.
43. Ulrich-Vinther M, Carmody EE, Goater JJ, et al. Recombinant adenoassociated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002;84:1405.
44. Carmody EE, Schwarz EM, Puzas JE, et al. Viral interleukin-10 gene inhibition of inflammation, osteoclastogenesis, and bone resorption in response to titanium particles. Arthritis Rheum 2002;46:1298.
45. Shanbhag AS, Hasselman CT, Rubash HE. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res 1997;344:33.
46. Iwase M, Kim KJ, Kobayashi Y, et al. A novel bisphosphonate inhibits inflammatory bone resorption in a rat osteolysis model with continuous infusion of polyethylene particles. J Orthop Res 2002;20:499.
47. von Knoch F, Heckelei A, Wedemeyer C, et al. The effect of simvastatin on polyethylene particle-induced osteolysis. Biomaterials 2005; 26:3549.
48. Yang SY, Mayton L, Wu B, et al. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethyleneinduced osteolysis in a murine model. Arthritis Rheum 2002;46:2514.
49. Dong L, Wang R, Zhu YA, et al. Antisense oligonucleotide targeting TNF-alpha can suppress Co-Cr-Mo particle-induced osteolysis. J Orthop Res 2008;26:1114.